Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

882 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Similar Piperacillin/Tazobactam Target Attainment in Obese versus Nonobese Patients despite Differences in Interstitial Tissue Fluid Pharmacokinetics.
Busse D, Simon P, Petroff D, Dorn C, Schmitt L, Bindellini D, Kratzer A, Dietrich A, Zeitlinger M, Huisinga W, Michelet R, Wrigge H, Kloft C. Busse D, et al. Among authors: schmitt l. Pharmaceutics. 2021 Aug 31;13(9):1380. doi: 10.3390/pharmaceutics13091380. Pharmaceutics. 2021. PMID: 34575456 Free PMC article.
Evaluation of the MeroRisk Calculator, A User-Friendly Tool to Predict the Risk of Meropenem Target Non-Attainment in Critically Ill Patients.
Liebchen U, Klose M, Paal M, Vogeser M, Zoller M, Schroeder I, Schmitt L, Huisinga W, Michelet R, Zander J, Scharf C, Weinelt FA, Kloft C. Liebchen U, et al. Among authors: schmitt l. Antibiotics (Basel). 2021 Apr 20;10(4):468. doi: 10.3390/antibiotics10040468. Antibiotics (Basel). 2021. PMID: 33924047 Free PMC article.
Comparative Plasma and Interstitial Tissue Fluid Pharmacokinetics of Meropenem Demonstrate the Need for Increasing Dose and Infusion Duration in Obese and Non-obese Patients.
Busse D, Simon P, Schmitt L, Petroff D, Dorn C, Dietrich A, Zeitlinger M, Huisinga W, Michelet R, Wrigge H, Kloft C. Busse D, et al. Among authors: schmitt l. Clin Pharmacokinet. 2022 May;61(5):655-672. doi: 10.1007/s40262-021-01070-6. Epub 2021 Dec 11. Clin Pharmacokinet. 2022. PMID: 34894344 Free PMC article. Clinical Trial.
High-Dosage Fosfomycin Results in Adequate Plasma and Target-Site Exposure in Morbidly Obese and Nonobese Nonhyperfiltration Patients.
Busse D, Simon P, Petroff D, El-Najjar N, Schmitt L, Bindellini D, Dietrich A, Zeitlinger M, Huisinga W, Michelet R, Wrigge H, Kloft C. Busse D, et al. Among authors: schmitt l. Antimicrob Agents Chemother. 2022 Jun 21;66(6):e0230221. doi: 10.1128/aac.02302-21. Epub 2022 May 23. Antimicrob Agents Chemother. 2022. PMID: 35603536 Free PMC article.
882 results